On ECHEMI
Home > Drugs > Shandong Hualu Pharmaceutical Co., Ltd.
Shandong Hualu Pharmaceutical Co., Ltd.
  • Founded in:

    1998-11-28
  • Country:

    China China
  • Address:

    No. 1 Hualu Street, Zhenxing Street, Chiping District, Liaocheng City, Shandong Province
  • Tax NO.:

    91371523168091268M
  • Registered Funds:

    50 million yuan
  • Website:

  • Email:

Related Drugs
Ethylenediamine Diacetate Sodium Chloride Injection
Ethylenediamine diacetate
Name Description Content CAS NO. Registered Holders
Clotrimazole

(1) Inhibit plasminogen activator, so that plasminogen cannot be activated into plasmin, thereby inhibiting the dissolution of fibrin and producing a hemostatic effect. (2) Promote the release of active substances by platelets, enhance platelet aggregation and adhesion. Shorten the coagulation time and produce a hemostatic effect. (3) Enhance capillary resistance and reduce capillary permeability, thereby reducing bleeding.

More

(1) Inhibit plasminogen activator, so that plasminogen cannot be activated into plasmin, thereby inhibiting the dissolution of fibrin and producing a hemostatic effect. (2) Promote the release of active substances by platelets, enhance platelet aggregation and adhesion. Shorten the coagulation time and produce a hemostatic effect. (3) Enhance capillary resistance and reduce capillary permeability, thereby reducing bleeding.

0
Matrine Sodium Chloride Injection
The main ingredient of this product is matrine, an alkaloid extracted from the fruit or aerial parts of Sophora alopecuroides L., a plant of the genus Sophora in the legume family.
Name Description Content CAS NO. Registered Holders
Matrine

Clears away heat and dampness, promotes diuresis and reduces jaundice, detoxifies, improves symptoms and signs of pathological hepatitis, reduces jaundice, and reduces enzymes; in vitro animal tests have shown that it can inhibit the replication of hepatitis B virus

More

Clears away heat and dampness, promotes diuresis and reduces jaundice, detoxifies, improves symptoms and signs of pathological hepatitis, reduces jaundice, and reduces enzymes; in vitro animal tests have shown that it can inhibit the replication of hepatitis B virus

519-02-8 8
Glycerol Sodium Chloride Injection
This product is a compound preparation, and its composition is: each bottle (250ml) contains 25g of glycerol and 2.25g of sodium chloride.
Name Description Content CAS NO. Registered Holders
Glycerol

It can effectively reduce intracranial pressure and intraocular pressure, especially the intracranial pressure.

More

It can effectively reduce intracranial pressure and intraocular pressure, especially the intracranial pressure.

25g 56-81-5 62
Sodium chloride

It can effectively reduce intracranial pressure and intraocular pressure, especially the intracranial pressure.

More

It can effectively reduce intracranial pressure and intraocular pressure, especially the intracranial pressure.

2.25g 7647-14-5 43
Glycerol Sodium Chloride Injection
This product is a compound preparation, and its composition is: each bottle (250ml) contains 25g of glycerol and 2.25g of sodium chloride.
Name Description Content CAS NO. Registered Holders
Glycerol

It can effectively reduce intracranial pressure and intraocular pressure, especially the intracranial pressure.

More

It can effectively reduce intracranial pressure and intraocular pressure, especially the intracranial pressure.

25g 56-81-5 62
Sodium chloride

It can effectively reduce intracranial pressure and intraocular pressure, especially the intracranial pressure.

More

It can effectively reduce intracranial pressure and intraocular pressure, especially the intracranial pressure.

2.25g 7647-14-5 43
Isosorbide dinitrate and glucose injection
Isosorbide dinitrate, glucose.
Name Description Content CAS NO. Registered Holders
Isosorbide dinitrate

Dilate blood vessels and improve myocardial ischemia

More

Dilate blood vessels and improve myocardial ischemia

87-33-2 23
GLUCOSE

58367-01-4 15
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.